drugset / Trial / NCT02628392
A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objectives of the study is to evaluate the efficacy, safety, and dose of DS-8500a compared with placebo in patients with type 2 diabetes mellitus.
Timeline
- Start
- 2015-11
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FIRUGLIPEL | Small molecule | 25 mg | Oral |
| Subject | FIRUGLIPEL | Small molecule | 50 mg | Oral |
| Subject | FIRUGLIPEL | Small molecule | 75 mg | Oral |
| Comparator | Sitagliptin | Small molecule | — | Oral |